Petra Kristel

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities.

Journal: Nature communications

Published: October 13, 2025

Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.

Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancer.

Journal: Research square

Published: January 03, 2024

A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.

A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.

Journal: NPJ precision oncology

Published: December 04, 2023

Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.

Ductal carcinoma in situ develops within clonal fields of mutant cells in morphologically normal ducts.

Journal: The Journal of pathology

Published: November 30, 2023

Archival single-cell genomics reveals persistent subclones during DCIS progression.

Archival single-cell genomics reveals persistent subclones during DCIS progression.

Journal: Cell

Published: January 08, 2023

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

A living biobank of patient-derived ductal carcinoma in situ mouse-intraductal xenografts identifies risk factors for invasive progression.

Journal: Cancer cell

Published: August 16, 2022

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.

Homologous recombination deficiency derived from whole-genome sequencing predicts platinum response in triple-negative breast cancers.

Journal: Nature communications

Published: April 14, 2022

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer.

Journal: Nature genetics

Published: September 17, 2021

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.

Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance.

Journal: NPJ breast cancer

Published: September 06, 2021

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: April 11, 2018

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.

Journal: Journal of the National Cancer Institute

Published: December 02, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026